BioTech PLUR

Pluri Prices $3.3 Mln Registered Direct Offering, Concurrent Private Placement

(RTTNews) - Pluri Inc. (PLUR) on Thursday announced a securities purchase agreement with a healthcare-focused institutional investor for the purchase and sale of 2.23 million common shares, or common share equivalents, at $1.50 per share in a registered direct offering.

In a concurrent private placement, Pluri will issue unregistered warrants to purchase up to 2.23 million common shares at an exercise price of $1.65 per share. The warrants will be exercisable six months after issuance and expire five and a half years from issuance.

The offering is expected to generate gross proceeds of approximately $3.3 million, before fees and other offering expenses. Pluri plans to use the net proceeds for working capital and general corporate purposes.

The offering is expected to close on or about August 28, 2026, subject to customary closing conditions.

A.G.P./Alliance Global Partners is acting as the sole placement agent.

As of March 31, 2026, cash, cash equivalents, short-term bank deposits, and restricted cash amounted to $9.55 million.

Pluri shares have traded between $1.45 and $5.29 over the last year.

PLUR closed Thursday's trade at $1.53, up 3.38%.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available